Denali Therapeutics, Inc. (DNLI)
19.26
+0.03
(+0.16%)
USD |
NASDAQ |
Apr 13, 10:56
Denali Therapeutics EPS Diluted (Quarterly) : -0.7326 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.482 |
| Protalix Biotherapeutics, Inc. | -0.0684 |
| Biogen, Inc. | -0.3333 |
| Agenus, Inc. | -0.301 |
| Curis, Inc. | 1.229 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.55M |
| Total Expenses (Quarterly) | 128.55M |
| Enterprise Value | 2.224B |
| Earnings Yield | -15.42% |
| Normalized Earnings Yield | -15.42 |